Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
Stage/Subtype:  Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Results 1-4 of 4 for your search:
Start Over
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SCT 0208, NCT00679536
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 60
Sponsor: Other
Protocol IDs: 2008-0363, NCI-2012-01630, NCT00857389
Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Phase: Phase I
Type: Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000491633, DFCI-05030, MDA-2005-0695, NCT00376480
Autologous T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 26
Sponsor: Other
Protocol IDs: 13-052, NCT01860937
Start Over